Company entering major new phase in brand building and revenue generating

FORT LEE, N.J., July 16, 2012 /PRNewswire/ -- Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics® Company is proud to announce today that it retained SSPR Public Relations Services (www.sspr.com), a top 20 full service Public Relations firm with offices in Chicago, Silicon Valley, New York and Colorado to handle Herborium strategic public relations and marketing communications.
This move comes at a time when Herborium Group begins to enter a new growth phase with commercialization of its unique, herbal, sexual health products for Women and Men, along with growth of its Botanical Therapeutic® Acne Treatment, and an entry into the multi-billion dollar Energy Drink market sector to begin in September.

"SSPR 30 year expertise in product, brand and financial communications is second to none. Over the years SSPR maximized its clients' high profile exposure though coverage in a wide range of media including CNN, ABC, USA Today, The Wall Street Journal, Fox Business, Forbes, Time and many others. Retaining SSPR accomplishes our goal of creating a high level / high value market exposure and media awareness for our expected rapid growth products and for Herborium as an innovator in a sector of natural health," stated Dr. Agnes P. Olszewski, CEO and Chairwoman for Herborium Group.

"Consumers are disenchanted with traditional pharmaceuticals from reasons ranging from cost to safety and poor results. There is a rapidly growing market for natural healthcare alternatives," said Steve Simon CEO of SSPR. "Herborium Group has a clear competitive advantage that will assist us in telling the product story in the media and helping consumers find answers in their unmet healthcare needs," noted Mr. Simon.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com